| Hans-Günter Meyer-Thompson | Hepatitiden
No Consistent Pattern of HBV Reactivation With Direct-acting Antivirals for HCV
NEW YORK - The largest case review to date of hepatitis B virus (HBV) reactivation associated with direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection found no consistent pattern in terms of which patients are likely to develop this adverse event. (Reuters Health, 25.04.2017)